Drug
Eptifibatide clinical trials
Also written Integrilin.
- studies test it
- 21
- open now
- 1
- in phase 3
- 7
- first study started
- 2003
Keep track of what changes. Save the Eptifibatide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Development codes
Combined with it in one product
Studies by the year they started
21 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 4 |
| 2009 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2019 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 10
- Phase 3
- 7
- Phase 4
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 18
University of Alabama at Birmingham (2) · Brigham and Women's Hospital (2) · Washington University School of Medicine (1) · Organon and Co (1) · Sisse R. Ostrowski, MD PhD DMSc (1) · Arthur Pancioli (1) · University of Cincinnati (1) · Cardiology Research UBC (1)
Often tested with
Tested in the same studies.
Ticagrelor (2) · Iloprost (2) · Argatroban (1) · Clopidogrel (1) · Aspirin (1) · Tinzaparin (1)
Studies
Open first, then newest update. How each study uses Eptifibatide is read from its arms, and is right about nine times in ten.
Testing it · 21
- Eptifibatide for Extended Window Ischemic Stroke After ThrombolysisNot yet recruitingPhase 3Xinqiao Hospital of ChongqingNCT07347626Written as Eptifibatide (Integrilin)
- Multi-arm Optimization of Stroke ThrombolysisCompletedPhase 3Washington University School of MedicineNCT03735979Written as Eptifibatide
- EARLY ACS: Early Glycoprotein IIb/IIIa Inhibition in Patients With Non-ST-segment Elevation Acute Coronary Syndrome (Study P03684AM2)(COMPLETED)CompletedPhase 3Organon and CoNCT00089895Written as Eptifibatide (Integrilin)
- Crushed Ticagrelor Versus Eptifibatide Bolus + ClopidogrelCompletedPhase 2University of Alabama at BirminghamNCT02925923Written as Eptifibatide
- Eptifibatide in Endovascular Treatment of Acute Ischemic Stroke (EPOCH)Status unknownPhase 3Ministry of Science and Technology of the People´s Republic of ChinaNCT03844594Written as Eptifibatide Injection
- Co-administration of Iloprost and Eptifibatide in Septic Shock PatientsCompletedPhase 2Sisse R. Ostrowski, MD PhD DMScNCT02204852Written as Iloprost+eptifibatide
- Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated InfusionCompletedPhase 2University of Alabama at BirminghamNCT01919723Written as Eptifibatide
- Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe SepsisTerminatedPhase 2Thrombologic ApSNCT01532544Written as Ilomedin and Integrilin
- Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic Stroke (CLEAR-FDR)CompletedPhase 2Arthur PancioliNCT01977456Written as Eptifibatide
- Eptifibatide and ST Segment Resolution Following Primary PCITerminatedPhase 3Medstar Health Research InstituteNCT00812435Written as eptifibitide
- Study of the Combination Therapy of Rt-PA and Eptifibatide to Treat Acute Ischemic StrokeCompletedPhase 2University of CincinnatiNCT00894803Written as Eptifibatide
- BRIEF-PCI: Brief Infusion of Eptifibatide Following Percutaneous Coronary InterventionCompletedPhase 4Cardiology Research UBCNCT00111566Written as eptifibatide
- Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-upCompletedPhase 4Medical University of SilesiaNCT01863134Written as Eptifibatide
- A Safety Study of Eptifibatide in Patients With Sickle Cell DiseaseTerminatedPhase 1/2University of North Carolina, Chapel HillNCT00834899Written as Eptifibatide
- Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)CompletedPhase 2National Institute of Neurological Disorders and Stroke (NINDS)NCT00061373Written as eptifibatide
- Efficacy Of Eptifibatide Compared To Abciximab In Primary Percutaneous Coronary Intervention (PCI) For Acute ST Elevation Myocardial Infarction (STEMI)CompletedPhase 3GlaxoSmithKlineNCT00426751Written as Eptifibatide
- A Safety/Efficacy Study of Intracoronary Integrilin to Improve Balloon Angioplasty Outcomes for the Treatment of Heart AttacksTerminatedPhase 2Brigham and Women's HospitalNCT00719914Written as eptifibatide
- The INtegrilin Plus STenting to Avoid Myocardial Necrosis Trial (INSTANT)TerminatedPhase 4University of Turin, ItalyNCT01454440Written as Eptifibatide
- INSTANT: INtegrilin Plus STenting to Avoid Myocardial Necrosis TrialCompletedPhase 3Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUSNCT00638976Written as eptifibatide
- Effectiveness of Intracoronary Injection of Eptifibatide in Primary Coronary Intervention in STEMI PatientsStatus unknownPhase 2Assaf-Harofeh Medical CenterNCT00945308Written as Eptifibatide
See all 21 studies that test Eptifibatide →
As the comparator · 3 — what is tested is compared with Eptifibatide
- Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary InterventionCompletedPhase 2MedicureNCT01522417Written as Eptifibatide
- Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive StrategyCompletedPhase 3SanofiNCT01076764Written as Eptifibatide
- Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary SyndromeCompletedPhase 2SanofiNCT00317395Written as eptifibatide
Codes
What other systems call Eptifibatide · ClinicalTrials.gg INT006739
- MeSH (NLM) D000077542EptifibatideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) NA8320J834EPTIFIBATIDEConfirmed FDA, NLM, Wikidata
- RxNorm 75635Confirmed FDA, Wikidata
- Wikidata Q2295855eptifibatideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47516EptifibatideOne source FDA
- DrugBank DB00063One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077542 | Eptifibatide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | NA8320J834 | EPTIFIBATIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 75635 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2295855 | eptifibatide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47516 | Eptifibatide | One source FDA |
| DrugBank | DB00063 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.